The membrane-bound rat serotonin transporter, SERT1, is an oligomeric protein  by Jess, Urda et al.
FEBS Letters 394 (1996) 44~46 FEBS 17522 
The membrane-bound rat serotonin transporter, SERT1, is an oligomeric 
protein 
Urda Jess, Heinrich Betz, Patrick Schloss* 
Abteilung Neurochemie, Max-Planck-lnstitut fiir Hirnforschung, Deutschordenstrasse 46, 60528 FrankJurt, Germany 
Received 31 July 1996 
Abstract The synaptic actions of the neurotransmitter seroto- 
nin are terminated by a selective re-uptake system located in the 
axonal membrane. To gain information about the quaternary 
structure of this membrane protein, we transiently expressed the 
recombinant rat serotonin transporter, SERT1, in human 
embryonic kidney 293 cells. Treatment with sulfhydryl oxidizing 
agents and the homobifunctional cross-linker dimethyl suber- 
imidate (DMS) generated adducts of 130-180 kDa and 220-270 
kDa, respectively. These data indicate an oligomeric structure of 
SERT1. 
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1. Introduction 
The neurotransmitter serotonin (5-hydroxytryptamine, 5- 
HT) modulates many sensory and behavioral processes in 
the nervous system and plays an important role in mood dis- 
orders, such as depression and anxiety [1]. Its rapid re-uptake 
from the synaptic left terminates serotoninergic signal trans- 
duction, a process mediated by the Na--/CI -dependent sero- 
tonin transporter. Serotonin uptake inhibitors are clinically 
used as potent antidepressants and have allowed a pharmaco- 
logical characterization f the serotonin transporter in mem- 
brane preparations from different species [1]. 
Cloning of serotonin transporter cDNAs from rat, human 
and Drosophila revealed that the predicted proteins are highly 
homologous to each other and represent members of a larger 
neurotransmitter ransporter superfamily [2,3]. Analysis of the 
deduced amino acid sequences indicates that the encoded 
polypeptides form integral membrane proteins with 12 puta- 
tive membrane spanning segments. Heterologous expression 
of the cloned rat serotonin transporter (SERT1) in Xenopus 
oocytes and mammalian cells generates Na+-dependent 5-HT 
uptake, which is sensitive to antidepressants and exhibits a 
pharmacological profile similar to that of the native transport 
system [4,5]. Thus, transfection with a single cDNA confers 
expression of functional serotonin transport of well-defined 
pharmacology onto non-neuronal cells. However, little is 
known about the structural organization of this and other 
neurotransmitter transport systems in the membrane. 
To investigate the quaternary structure of the membrane- 
bound serotonin transporter, we performed cross-linking stud- 
ies on SERT1 expressed in the human embryonic kidney cell 
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line 293 (HEK-293 cells). Here, we show that recombinant 
SERT1 can form dimeric and tetrameric adducts upon treat- 
ment of SERT1 containing membranes with sulfhydryl oxidiz- 
ing agents. Use of the bifunctional cross-linker DMS gave 
similar results, indicating that SERT1 is an oligomeric mem- 
brane protein. 
2. Materials and methods 
2.1. Expression of SERT1 in HEK-293 cells 
Cell transfection with the SERT1 cDNA and preparation of mem- 
branes was performed as described previously [6]. 
2.2. Cross-linking with diamide (azodicarboxylic a id [diethylamide]) 
and (o-phenanthroline)2-Cu ~+ 
Membrane preparations from SERT1 transfected HEK-293 cells 
(20-50 Bg total protein) were incubated in freshly dissolved iamide 
or (o-phenanthroline)2-Cu + at room temperature for different ime 
periods. To avoid unspecific disulfide formation, free thiols were 
acetylated by preincubation f the membranes in 40 mM iodoaceta- 
mide at 37°C prior to oxidation. Cross-linking with (o- 
phenanthroline)2-Cu + was terminated by the addition of 1 mM 
EDTA, and cross-linking with diamide by rapid centrifugation of
the membranes and resuspension in non-reducing sample buffer prior 
to gel electrophoresis. 
2.3. Cross-linking with dimethyl suberimidate (DMS) 
DMS dissolved in 0.2 M triethanolamine (pH 8.5) was added to 
membrane preparations from SERT1 transfected HEK-293 cells (2~ 
50 I-tg total protein) to a final concentration f 0.1 mM. After incuba- 
tion for 5-60 min at room temperature, the cross-linking process was 
terminated by the addition of 1/10 volume of 1 M Tris-HC1, pH 7.5. 
2.4. Electrophoresis and immunoblotting 
Sodium dodecyl sulfate polyacrylamide g l electrophoresis (SDS- 
PAGE) on 7.5%, or on 3.5-10% gradient, gels was performed accord- 
ing to Laemmli [7]. In all experiments, the samples were not boiled 
prior to SDS-PAGE, since this resulted in a loss of SERT1 immunore- 
activity. For immunoblotting, the separated proteins were transferred 
to nitrocellulose in a horizontal semi-dry electroblotting apparatus, 
and the blots reacted with the affinity purified SERT1 specific anti- 
serum AS968 followed by a horseradish peroxidase coupled secondary 
antibody in combination with the ECL detection system (Amersham) 
as described [8]. 
3. Results 
3.1. Immunoblotting of membrane bound SERT1 
Membrane preparations from transfected HEK-293 cells 
expressing the serotonin transporter, and from control 
mock-transfected cells, were subjected to SDS-PAGE under 
reducing (5% (v/v) 13-mercaptoethanol or 100 mM dithiothrei- 
tol (DTT)) or non-reducing conditions, transferred to nitro- 
cellulose and then reacted with a SERT1 specific antiserum 
[7]. Under non-reducing conditions, most of the immunoreac- 
tivity was detected in two broad bands at 130-180 kDa and 
220 270 kDa (Fig. 1). In addition, a minor double band was 
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seen at 62/56 kDa; the latter corresponds to the monomeric 
SERT1 polypeptide. None of these bands was found in mem- 
brane preparations from mock-transfected cells. Under reduc- 
ing conditions, all SERT1 specific immunoreactivity was de- 
tected at 130-180 kDa and 62/56 kDa; no cross-reacting 
material was seen in the range of 220 270 kDa. This suggests 
that SERT1 can form higher molecular weight oligomers of 
the monomeric 62 kDa SERT1 polypeptide, which are disul- 
fide-linked. 
3.2. Cross-linking of SERT1 expressing cell membranes with 
(o-phenanthroline) 2-Cu e+ and diamide 
To further investigate the involvement of disulfides in the 
formation of SERT1 adducts exhibiting reduced mobility 
upon SDS-PAGE, we treated membranes from SERT1 ex- 
pressing cells with the specific sulfhydryl oxidizing agents (o- 
phenanthroline)2-Cu 2+ and diamide. To avoid unspecific di- 
sulfide formation, free sulfhydryl groups were blocked with 
iodoacetamide prior to reduction with 100 mM DTT, Under 
these conditions, SERTI immunoreactivity electrophoresed at 
apparent molecular weights of ,~62 kDa and 130 180 kDa 
(Fig. 2, lane 1). Oxidation of the reduced membranes with 
both (o-phenanthroline)2-Cu 2+ and diamide resulted in the 
appearance of 220-270 kDa adduct and increased levels of 
the 130-180 kDa band (Fig. 2, lanes 2, 3) concomitantly 
with a decrease in 62 kDa immunoreactivity. Subsequent re- 
duction of the oxidized membrane preparation re-converted 
the 220-270 kDa adduct completely, and the 130-180 kDa 
adduct partially, into the 62 kDa SERT1 monomer (Fig. 2, 
lane 4). This is consistent with disulfide bridges that are 
poorly accessible to DTT being implicated in 130-180 kDa 
adduct formation. In contrast, the disulfide bridge(s) generat- 
ing the 220-270 kDa complex appear(s) to be readily reduced 
by DTT or [3-mercaptoethanol. 
3.3. Cross-linking of membrane bound SERT1 with DMS 
We also treated SERT1 containing membrane preparations 
with the homobifunctional cross-linker DMS for various time 
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Fig. 1. Immunoblotting of membrane preparations from transfected 
HEK-293 cells under non-reducing (lanes 1 and 2) and reducing 
conditions (lane 3). Membranes (~ 30 Ixg per lane) prepared from 
HEK-293 cells transfected with the SERT1 cDNA (lanes 2 and 3) 
or from mock-transfected cells (lane 1) were subjected to SDS- 
PAGE without (lanes 1 and 2) or with (lane 3) prior reduction by 
5% (v/v) I~-mercaptoethanol. M lecular weight standards (MWS) are 
given in kDa. 
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Fig. 2. Sulfhydryl specific ross-linking of SERT1 containing mem- 
branes with diamide and (o-phenanthrolineh-Cu 2+. Free thiols were 
blocked with 40 mM iodoacetamide before reduction with 100 mM 
DTT (lane 1); aliquots of these membranes (~20 ~tg) were then 
oxidized with either 0.5 mM (o-phenanthroline)2-Cu 2÷ (lane 2) or 
150 ~M diamide (lane 3). An aliquot of the diamide oxidized mem- 
branes was thereafter treated with 100 mM DTT (lane 4). SDS- 
PAGE was performed under non-reducing conditions. 
periods (Fig. 3) and at different cross-linker concentrations 
(not shown). The resulting SERT1 adducts then were immu- 
nodetected after resolution on SDS-PAGE under reducing 
conditions. Treatment with 0.1 mM DMS for up to 45 min 
resulted in the appearance of the SERT1 specific adduct of 
220-270 kDa; its intensity increased upon prolonged incuba- 
tion with the cross-linker (Fig. 3). However, in contrast o the 
results obtained with sulfhydryl oxidizing agents shown in 
Fig. 2, the amount of high molecular weight adduct was 
low, and no decrease in the 62 kDa monomer could be de- 
tected. At high DMS concentrations, large aggregates were 
formed which were retained in the stacking gel (data not 
shown). 
These data show that a major fraction of the SERT1 pro- 
tein in membrane preparations of the transfected cells exists in 
higher molecular weight oligomers. 
4. Discussion 
Chemical cross-linking has been widely used to investigate 
the subunit composition and the native molecular size of 
membrane proteins [9-11]. Here, we applied this technique 
to the recombinant SERT1 expressed in a mammalian cell 
line. Upon SDS-PAGE, the SERT1 polypeptide and derived 
adducts were identified by immunoblotting with the polyclo- 
nal antiserum AS 968, which has been shown to specifically 
recognize both the recombinant protein as well as the native 
transporter in brain sections [8]. Under reducing conditions, 
AS968 mostly revealed monomeric SERT1 as a doublet of 
apparent molecular weights of ,~ 62 kDa and, to a lesser ex- 
tent, ,~ 57 kDa. The same result has also been obtained by 
Quian et al. [12] for SERT1 expressed in HeLa cells. These 
authors have shown that the immunoreactive band of higher 
electrophoretic mobility results from deglycosylation f the 62 
kDa protein. Thus, both glycosylated and non-glycosylated 
forms of SERT1 seem to be present in our membrane prep- 
arations; presumably the latter reflect newly synthesized 
transporter, which still resides in intracellular membrane com- 
partments. 
Upon non-reducing SDS-PAGE, additional SERT1 immu- 
noreactivity was observed in two broad bands at 130-180 kDa 
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Fig. 3. Compositional analysis of SERTI adducts produced by 
cross-linking with DMS. Membranes from SERT1 transfected cells 
(30 gg) were treated with 0,1 mM DMS for 5 min (lane 2), 25 min 
(lane 3) and 45 min (lane 4). In lane 1, DMS was omitted. The 
samples were resolved by SDS-PAGE after reduction by 5% (v/v) 13- 
mercaptoethanol, transferred to nitrocellulose, and SERT1 adducts 
were immunodetected as described in Section 2. 
and 22~270 kDa, respectively, the intensities of these bands 
varying considerably between different experiments. Due to 
the heterogeneity of these high molecular weight adducts, an 
accurate determination of their molecular sizes proved diffi- 
cult. Thiol oxidation of the membranes with both (o- 
• 2 +  phenanthrollne)2-Cu and diamide before electrophoretic 
analysis under non-reducing conditions increased the abun- 
dance of these higher molecular weight adducts with a parallel 
decrease of the 62/57 kDa antigen. Reduction of the oxidized 
membranes converted the 220-270 kDa band completely, and 
the 130-180 kDa band partially, into monomeric SERT1. 
These findings are consistent with the immunoreactive high- 
molecular weight adducts representing oligomeric omplexes 
of SERTI. Since the 220-270 kDa band was also seen in non- 
reduced membrane preparations which had not been subjected 
to thiol oxidation, we propose that this adduct represents a 
tetrameric disulfide-stabilized form of the SERT1 polypeptide. 
In contrast, the 130-180 kDa adduct was also observed in the 
presence of reducing agents, although to a lesser extent than 
under non-reducing conditions. Interestingly, 60 kDa and 130 
kDa SERT1 bands have also been found in membrane prep- 
arations from insect cells after transfection with a recombi- 
nant baculovirus [13]. In this report, the 130 kDa band was 
interpreted as a putative dimeric form of the SERT1 protein. 
Collectively, this finding and the data presented above are 
consistent with the 130 kDa adduct representing a disulfide 
linked dimer, whose disulfide bonds are poorly accessible to 
reducing agents. However, for a definitive compositional nal- 
ysis of the higher molecular weight adducts, cross-linking ex- 
periments on the purified SERTI protein will be required. 
Our interpretation that membrane bound SERT1 forms 
tetramers is in good agreement with radiation inactivation 
studies on the dopamine transporter (DAT1), which also in- 
dicate a tetrameric structure for this membrane protein [14]. 
SERTI and DATI belong to the same superfamily of Na+/ 
C1--coupled neurotransmitter transporters and share a high 
degree of amino acid identity. It therefore is reasonable to 
assume that both proteins have a common quaternary struc- 
ture, a conclusion corroborated by the results described 
above. Interestingly, the hexose transporter GLUT1 also has 
been shown to exist as a mixture of homodimers and homo- 
tetramers, with an intramolecular disulfide bridge promoting 
GLUT1 tetramerization [15,16]. GLUT1 is another integral 
membrane protein with 12 putative membrane spanning seg- 
ments; however, it displays no sequence homology to the 
monoamine transporters mentioned above. Thus, the similar 
oligomeric structure of all these transporter proteins might 
reflect a general structural requirement for effective substrate 
translocation. 
Previous studies have shown that disulfides are critical de- 
terminants of serotonin transporter function. Disulfide oxida- 
tion has been reported to stimulate serotonin transport in 
mouse platelets [17], whereas reduction increases the affinity 
for imipramine, a potent serotonin uptake inhibitor [18]. 
These observations may indicate that the binding affinity of 
SERT1 is altered upon oligomerization. This again shows 
parallels with the hexose transporters, where the functional 
properties of GLUT1 have been found to depend on its state 
of oligomerization [19]. 
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